1 |
Fulda S, Debatin KM. 2006. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25: 4798-4811.
DOI
|
2 |
Kim Y, Cha S, Seo T. 2016. Activation of the phosphatidylinositol 3-kinase/Akt pathway by viral interferon regulatory factor 2 of Kaposi's sarcoma-associated herpesvirus. Biochem. Biophys. Res. Commun. 470: 650-656.
DOI
|
3 |
Choi YB, Sandford G, Nicholas J. 2012. Human herpesvirus 8 interferon regulatory factor-mediated BH3-only protein inhibition via Bid BH3-B mimicry. PLoS Pathog. 8: e1002748.
DOI
|
4 |
Hwang KY, Choi YB. 2016. Modulation of mitochondrial antiviral signaling by human herpesvirus 8 interferon regulatory factor 1. J. Virol. 90: 506-520.
DOI
|
5 |
Vogelstein B, Lane D, Levine AJ. 2000. Surfing the p53 network. Nature 408: 307-310.
DOI
|
6 |
Lee HR, Kim MH, Lee JS, Liang C, Jung JU. 2009. Viral interferon regulatory factors. J. Interferon Cytokine Res. 29: 621-627.
DOI
|
7 |
Wang S, Zhao Y, Aguilar A, Bernard D, Yang CY. 2017. Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapy: Progress and Challenges. Cold Spring Harb Perspect Med. 7(5). pii: a026245..
|
8 |
Vazquez A, Bond EE, Levine AJ, Bond GL. 2008. The genetics of the p53 pathway, apoptosis and cancer therapy. Nat. Rev. Drug Discov. 7: 979-987.
DOI
|
9 |
Peter ME, Hadji A, Murmann AE, Brockway S, Putzbach W, Pattanayak A, et al. 2015. The role of CD95 and CD95 ligand in cancer. Cell Death Differ. 22: 549-559.
DOI
|
10 |
Shin YC, Nakamura H, Liang X, Feng P, Chang H, Kowalik TF, et al. 2006. Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1. J. Virol. 80: 2257-2266.
DOI
|
11 |
Burysek L, Yeow WS, Lubyova B, Kellum M, Schafer SL, Huang YQ, et al. 1999. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J. Virol. 73: 7334-42.
DOI
|
12 |
Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. 1995. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 86: 1276-1280.
DOI
|
13 |
Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, et al. 1996. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88: 645-656.
DOI
|
14 |
Ganem D. 2010. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J. Clin. Invest. 120: 939-949.
DOI
|
15 |
Lee HR, Amatya R, Jung JU. 2015. Multi-step regulation of innate immune signaling by Kaposi's sarcoma-associated herpesvirus. Virus Res. 209: 39-44.
DOI
|
16 |
Li M, Lee H, Guo J, Neipel F, Fleckenstein B, Ozato K, et al. 1998. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J. Virol. 72: 5433-40.
DOI
|
17 |
Li M, Damania B, Alvarez X, Ogryzko V, Ozato K, Jung JU. 2000. Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor. Mol. Cell Biol. 20: 8254-8263.
DOI
|
18 |
Lee HR, Toth Z, Shin YC, Lee JS, Chang H, Gu W, et al. 2009. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 targets MDM2 to deregulate the p53 tumor suppressor pathway. J. Virol. 83: 6739-6747.
DOI
|
19 |
Seo T, Park J, Lee D, Hwang SG, Choe J. 2001.Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis. J. Virol. 75: 6193-6198.
DOI
|
20 |
Chavoshi S, Egorova O, Lacdao IK, Farhadi S, Sheng Y, Saridakis V. 2016. Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 protein as a novel interaction partner of human Deubiquitinase USP7. J. Biol. Chem. 291: 6281-6291.
DOI
|
21 |
Lee HR, Choi WC, Lee S, Hwang J, Hwang E, Guchhait K, et al. 2011. Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein. Nat. Struct. Mol. Biol. 18: 1336-1344.
DOI
|
22 |
Pantry SN, Medveczky PG. 2009. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication. Semin. Cancer Biol. 19: 153-157.
DOI
|
23 |
Fuld S, Cunningham C, Klucher K, Davison AJ, Blackbourn DJ. 2006. Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. J. Virol. 80: 3092-3097.
DOI
|
24 |
Baresova P, Pitha PM, Lubyova B.2013. Distinct roles of Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factors in inflammatory response and cancer. J. Virol. 87: 9398-9410.
DOI
|
25 |
Takaoka A, Tamura T, Taniguchi T. 2008. Interferon regulatory factor family of transcription factors and regulation of oncogenesis. Cancer Sci. 99: 467-478.
DOI
|
26 |
Park J, Lee MS, Yoo SM, Jeong KW, Lee D, Choe J, et al. 2007. Identification of the DNA sequence interacting with Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 1. J. Virol. 81: 12680-12684.
DOI
|
27 |
Jacobs SR, Gregory SM, West JA, Wollish AC, Bennett CL, Blackbourn DJ, et al. 2013. The viral interferon regulatory factors of kaposi's sarcoma-associated herpesvirus differ in their inhibition of interferon activation mediated by toll-like receptor 3. J. Virol. 87: 798-806.
DOI
|
28 |
West AP, Khoury-Hanold W, Staron M, Tal MC, Pineda CM, Lang SM, et al. 2015. Mitochondrial DNA stress primes the antiviral innate immune response. Nature 520: 553-557.
DOI
|
29 |
Ma Z, Jacobs SR, West JA, Stopford C, Zhang Z, Davis Z, et al. 2015. Modulation of the cGAS-STING DNA sensing pathway by gammaherpesviruses. Proc. Natl. Acad. Sci. USA 112: E4306-15.
DOI
|
30 |
Jenner RG, Alba MM, Boshoff C, Kellam P. 2001. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J. Virol. 75: 891-902.
DOI
|
31 |
Burysek L, Yeow WS, Pitha PM. 1999. Unique properties of a second human herpesvirus 8 -encoded interferon regulatory factor (vIRF-2). J. Hum. Virol. 2: 19-32.
|
32 |
Areste C, Mutocheluh M, Blackbourn DJ. 2009. Identification of caspase-mediated decay of interferon regulatory factor-3, exploited by a Kaposi sarcoma-associated herpesvirus immunoregulatory protein. J. Biol. Chem. 284: 23272-23285.
DOI
|
33 |
Burysek L, Pitha PM. 2001. Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J. Virol. 75: 2345-2352.
DOI
|
34 |
Rivas C, Thlick AE, Parravicini C, Moore PS, Chang Y. 2001. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cellspecific latent viral protein that inhibits p53. J. Virol. 75: 429-438.
DOI
|
35 |
Hew K, Dahlroth SL, Venkatachalam R, Nasertorabi F, Lim BT, Cornvik T, et al. 2013. The crystal structure of the DNAbinding domain of vIRF-1 from the oncogenic KSHV reveals a conserved fold for DNA binding and reinforces its role as a transcription factor. Nucleic Acids Res. 41: 4295-4306.
DOI
|
36 |
Seo T, Park J, Choe J. 2005. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling. Cancer Res. 65: 1738-1747.
DOI
|
37 |
Hu H, Dong J, Liang D, Gao Z, Bai L, Sun R, et al. 2016. Genome-wide mapping of the binding sites and structural analysis of Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 2 reveal that it is a DNAbinding transcription factor. J. Virol. 290: 1158-1168.
|
38 |
Koch S, Damas M, Freise A, Hage E, Dhingra A, Ruckert J, et al. 20019. Kaposi's sarcoma-associated herpesvirus vIRF2 protein utilizes an IFN-dependent pathway to regulate viral early gene expression. PLoS Pathog. 15: e1007743.
DOI
|
39 |
Lee HR, Li F, Choi UY, Yu HR, Aldrovandi GM, Feng P, et al. 2018. Deregulation of HDAC5 by viral interferon regulatory factor 3 plays an essential role in Kaposi's sarcomaassociated herpesvirus-induced lymphangiogenesis. Mbio 9(1). pii: e02217-17
|
40 |
Xi X, Persson LM, O'Brien MW, Mohr I, Wilson AC. 2012. Cooperation between viral interferon regulatory factor 4 and RTA to activate a subset of Kaposi's sarcoma-associated herpesvirus lytic promoters. J. Virol. 86: 1021-1033.
DOI
|
41 |
Lee HR, Doganay S, Chung B, Toth Z, Brulois K, Lee S, et al. 2014. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) targets expression of cellular IRF4 and the Myc gene to facilitate lytic replication. J. Virol. 88: 2183-2194.
DOI
|
42 |
Wies E, Hahn AS, Schmidt K, Viebahn C, Rohland N, Lux A, et al. 2009. The Kaposi's Sarcoma-associated Herpesvirusencoded vIRF-3 inhibits cellular IRF-5. J. Biol. Chem. 284: 8525-8538.
DOI
|
43 |
Lubyova B, Kellum MJ, Frisancho AJ, Pitha PM. 2004. Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J. Biol. Chem. 279: 7643-7654.
DOI
|
44 |
Lubyova B, Pitha PM. 2000. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J. Virol. 74: 8194-8201.
DOI
|
45 |
Joo CH, Shin YC, Gack M, Wu L, Levy D, Jung JU. 2007. Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcomaassociated herpesvirus viral IRF homolog vIRF3. J. Virol. 81: 8282-8292.
DOI
|
46 |
Hwang SW, Kim D, Jung JU, Lee HR. 2017. KSHV-encoded viral interferon regulatory factor 4 (vIRF4) interacts with IRF7 and inhibits interferon alpha production. Biochem. Biophys. Res. Commun. 486: 700-705.
DOI
|
47 |
Green DR, Llambi F. 2005. Cell Death Signaling. Cold Spring Harb Perspect. Biol. 7(12).
|
48 |
Willis SN, Adams JM. 2005. Life in the balance: how BH3-only proteins induce apoptosis. Curr. Opin. Cell Biol. 17: 617-625.
DOI
|
49 |
Kirchhoff S, Sebens T, Baumann S, Krueger A, Zawatzky R, Li-Weber M, et al. 2002. Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter. J. Immunol. 168: 1226-1234.
DOI
|
50 |
Peter ME, Hellbardt S, Schwartz-Albiez R, Westendorp MO, Walczak H, Moldenhauer G, et al. 1995. Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death. Cell Death Differ. 2: 163-171.
|
51 |
Robinson BA, Estep RD, Messaoudi I, Rogers KS, Wong SW. 2012. Viral interferon regulatory factors decrease the induction of type I and type II interferon during rhesus macaque rhadinovirus infection. J. Virol. 86: 2197-2211.
DOI
|
52 |
Yu HR, Kim YJ, Lee HR. 2018. KSHV vIRF4 enhances BCL6 transcription via downregulation of IRF4 expression. Biochem. Biophys. Res. Commun. 496: 1128-1133.
DOI
|
53 |
Shaffer A L, Emre NC, Romesser PB, Staudt LM. IRF4: Immunity. Malignancy! Therapy? Clin. Cancer Res. 15: 2954- 2961.
DOI
|
54 |
Lee HR, Mitra J , Lee S, Gao SJ, Oh TK, Kim MH, et al. 2016. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 4 (vIRF4) perturbs the G1-S cell cycle progression via deregulation of the cyclin D1 gene. J. Virol. 90: 1139-1143.
DOI
|
55 |
Springgay LK, Fitzpatrick K, Park B, Estep RD, Wong SW. 2019. Rhesus macaque rhadinovirus encodes a viral interferon regulatory factor to disrupt promyelocytic leukemia nuclear bodies and antagonize type I interferon signaling. J. Virol. 93(6). pii: e02147-18.
|